T. Rowe Price Investment Management
MEDP icon

T. Rowe Price Investment Management’s Medpace MEDP Stock Holding History

T. Rowe Price Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13
Closed -$8K – 825
2025
Q4 		$8K Hold
13
– – ﹤0.01% 736
2025
Q3 		$7K Buy
+13
New +$5.68K ﹤0.01% 747

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Investment Management's MEDP Position: Q1 2026 in Review

T. Rowe Price Investment Management sold out of Medpace (MEDP) in Q1 2026, closing a stake of 13 shares — an estimated $8K sold.

T. Rowe Price Investment Management first reported a position in MEDP in Q3 2025 and held it in 2 quarters. The position peaked at $8K in Q4 2025. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • T. Rowe Price Investment Management reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • T. Rowe Price Investment Management sold 13 Medpace shares in Q1 2026, an estimated $8K.
  • T. Rowe Price Investment Management first reported a position in Medpace in Q3 2025 and held it in 2 quarters.
  • T. Rowe Price Investment Management's Medpace position peaked at $8K in Q4 2025.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.